Tag Archives: BIO CEO & Investor Conference

Voting Opens for BIO CEO & Investor Conference “Buzz of BIO”

BuzzofBIOLogo

Finalists in each of three categories have been named in this year’s Buzz of BIO contest sponsored by the 2017 BIO CEO & Investor Conference to be held February 13-14 at the Waldorf Astoria in New York. Voting opens today to choose winners in these three categories: Public Therapeutic Biotech – publically traded companies actively developing a therapeutic product intended for FDA review that addresses human health issues. Private Therapeutic Biotech – companies actively developing Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Nominations Open: Be the Buzz of BIO at the 2017 BIO CEO & Investor Conference

CEO-BuzzofBIO

The nomination period is underway for the Buzz of BIO contest at the 2017 CEO & Investor Conference! Winners receive complimentary conference registration, a company presentation in the corresponding track, and opportunities for promotion to industry leaders and investors including a spotlight in BioCentury Extra! The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Investor Forum Celebrates 15th Year with Record Number of Partnering Meetings

bio-4

The 15th Annual BIO Investor Forum wrapped up in San Francisco yesterday, having exceeded all prior years’ numbers of meetings arranged through the BIO One-on-One Partnering™ system. Both the conference and the partnering system are designed to help investors identify the latest trends and provide biotech innovators an opportunity to secure the funding necessary to bring their technologies to market. This year’s forum brought together over 880 attendees including 240 investors and 155 presenting companies. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers

bio-ceo-2016

The 18th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place this earlier this week in New York City at the Waldorf Astoria with more than 1,400 registrants, including over 600 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 6 fireside chats with biopharma CEOs as well as a special guest, New York Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Session Recap: Advances in Ophthalmology: Therapies for Saving Sight

ophthalmology panel at BIO CEO & Investor Conference

Monday at the BIO CEO & Investor Conference featured a 9:30am panel that offered a comprehensive perspective on what is happening in the world of ophthalmology today.  The panel was moderated by Tony Gibney, Managing Director, Leerink Partners. The panelists were: Jeffrey L. Cleland, PhD, Interim Chief Executive Officer, GrayBug Guy Eakins, PhD, Vice President, Scientific Affairs, BrightFocus Foundation Nouhad Husseini, Vice President, Business Development, Regeneron David P. Southwell, President and Chief Executive Officer, Inotek Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,